Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TDR Insider

Test price data shows major difference between Medicare lab fee schedule and private payers

This is an excerpt from a 1,500-word article in the November 7 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: THE DARK REPORT presents the lab industry’s first look at actual price […]

To access this post, you must purchase The Dark Report.

Test price data shows major difference between Medicare lab fee schedule and private payers Read More »

Health Diagnostics Laboratory lawsuit seeks $600M; will it establish a new precedent?

This is an excerpt from a 1,350-word article in the September 26 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: It’s never been done before, and the Health Diagnostics Laboratory lawsuit is

To access this post, you must purchase The Dark Report.

Health Diagnostics Laboratory lawsuit seeks $600M; will it establish a new precedent? Read More »

The newest threat to lab revenues: reference pricing in healthcare

This is an excerpt from a 1,600-word article in the September 6 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. CEO SUMMARY: It’s the newest threat to clinical lab survival. A new study shows exactly how reference pricing in healthcare is likely to work, as

To access this post, you must purchase The Dark Report.

The newest threat to lab revenues: reference pricing in healthcare Read More »

Score for Theranos after AACC: Fail.

This is an excerpt from a 1,600-word article in the August 15 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. SKEPTICS WHO WEREN’T EXPECTING MUCH from Theranos CEO Elizabeth Holmes at the recent American Association of Clinical Chemistry’s annual meeting were proved right: Instead of delivering

To access this post, you must purchase The Dark Report.

Score for Theranos after AACC: Fail. Read More »

New Threat To Community Lab Survival: CMS Clinical Lab Fee Schedule Cuts

This is an excerpt from a 2,000-word article in the July 5 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group. CEO SUMMARY: Everyone has read the basic facts, but THE DARK REPORT has gone further to analyze the real-world impact of the final rule from the Protecting

To access this post, you must purchase The Dark Report.

New Threat To Community Lab Survival: CMS Clinical Lab Fee Schedule Cuts Read More »

Up to 30,000 Theranos test results voided; Walgreen dumps partnership

This is an excerpt from a 1,000-word article in the June 13 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group.   EXECUTIVE SUMMARY: The disruptor’s plans have been thoroughly disrupted. As this issue of  THE DARK REPORT went to press, it was learned that Walgreens had announced

To access this post, you must purchase The Dark Report.

Up to 30,000 Theranos test results voided; Walgreen dumps partnership Read More »

AACC reveals details of its invitation to Theranos CEO

This is an excerpt from a 925-word article in the May 23 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group.  CEO SUMMARY: In its latest lab industry scoop, THE DARK REPORT has reached out to American Association of Clinical Chemistry (AACC) leaders to find out how

To access this post, you must purchase The Dark Report.

AACC reveals details of its invitation to Theranos CEO Read More »

Theranos Saga Just Keeps Getting More Intriguing

IT’S BEEN AN EVENTFUL COUPLE OF MONTHS for Theranos, the lab testing company that says its goal is to disrupt the clinical laboratory industry. Novelists cannot write fiction as compelling as the unfolding real story about this controversial company.

During March and April, The Wall Street Journal published a series of articles that revealed the extent of the problems Theranos had with CLIA inspections of its clinical laboratory in Newark, California. The Journal published its analysis of the CLIA inspection report and the serious deficiencies identified during lab inspections that happened last fall and earlier this year.

To access this post, you must purchase The Dark Report.

Theranos Saga Just Keeps Getting More Intriguing Read More »

;